Atomic Invest’s Merck MRK Stock Holding History

Atomic Invest’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$26.7K	Buy	184 +6	+3%	+$829	﹤0.01%	210
2026 Q2	$23K	Sell	178 -31	-15%	-$3.63K	﹤0.01%	191
2026 Q1	$24.7K	Buy	209 +59	+39%	+$6.81K	0.01%	167
2025 Q4	$15.9K	Buy	+150	New	+$14.1K	0.01%	168

Other funds holding MRK

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Atomic Invest's MRK Position: Q3 2026 in Review

Atomic Invest increased its Merck (MRK) stake by 3.4% in Q3 2026, buying an estimated $829 and bringing the position to 184 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #210.

Atomic Invest first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

Atomic Invest held 184 shares of Merck worth $26.7K as of Q3 2026.
Atomic Invest bought 6 Merck shares in Q3 2026, an estimated $829.
Merck made up ﹤0.01% of Atomic Invest's portfolio in Q3 2026, its #210 holding.
Atomic Invest first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Atomic Invest's 13F filing for Q3 2026, filed 13 Nov 2026.